having some joint pain in my ankles and knees. apparently a side effect of the #FOLFIRI #chemo #chemotherapy. not too bad, just took some acetaminophen to help. The chemo in general has actually massively reduced the pain from my #cancer since it is in my bones as well

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial - Signal Transduction and Targeted Therapy Signal Transduction and Targeted Therapy - First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type...

This phase 3 trial shows that cetuximab β plus #FOLFIRI significantly improves #ProgressionFreeSurvival, overall survival, and response rates compared to FOLFIRI alone in RAS/BRAF wild-type #MetastaticColorectalCancer with manageable toxicity.

#STTT:

6th #FOLFIRI chemo round! 💪🐼
There are lots of side effects, but I'd rather focus on crossing the finish line, hoping I'll get a break to give my body a chance to recover.
I still can’t understand why the cure has to be so destructive, though.
But you do what you have to do.
Happy Wednesday! 😘❤️

Cetuximab β plus #FOLFIRI improves progression-free & #OverallSurvival and response rates over FOLFIRI alone, with manageable safety, supporting its use as a first-line therapy for RAS/BRAF wild-type #MetastaticColorectalCancer. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...

Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial | Journal of Cli... PURPOSETo investigate whether intermittent treatment after an induction phase of first-line schedule of fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus panitumumab (PAN) prevents or delays the...

TTO intermitente c/fluorouracilo, leucovorina e irinotecán +panitumumab luego de inducción en pac c/CA colorrectal MT salvaje RAS/BRAF irresecable, mejora supervivencia libre de progresión en TTO c/menos toxicidad #FOLFIRI #panitumumab #mCRC ascopubs.org/doi/full/10....